about
Venous thromboembolic diseaseVenous Thromboembolism in Cancer: An Update of Treatment and Prevention in the Era of Newer AnticoagulantsEvidence-based case report: multiple thrombotic episodes associated with lenalidomide and dexamethasone therapy for multiple myelomaClinical problem solving: utility of sonography in oncologic patientsVenous thromboembolism in cancer patients: an underestimated major health problemAnticoagulant and Anti-thrombotic Treatments in the Management of Hematological Malignancies in a Home Care Program.Between Scylla and Charybdis: antithrombotic therapy in hematopoietic progenitor cell transplant patients.Venous thromboembolism in cancer patients.A retrospective study of venous thromboembolism in acute leukemia patients treated at the University of Texas MD Anderson Cancer Center.Patterns of Venous Thromboembolism Prophylaxis During Treatment of Acute Leukemia: Results of a North American Web-Based Survey.Venous thromboembolism in hematopoietic stem cell transplant recipients.Safety of anticoagulation in thrombocytopenic patients with hematologic malignancies: A case series.Aspirin Is Associated with Improved Survival in Severely Thrombocytopenic Cancer Patients with Acute Myocardial Infarction.Cell-based evaluation of changes in coagulation activity induced by antineoplastic drugs for the treatment of acute myeloid leukemiaVenous thromboembolism prophylaxis in hematopoietic stem cell transplantation patients: an international web-based survey of healthcare providers.Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997-2006CD138-negative myeloma cells regulate mechanical properties of bone marrow stromal cells through SDF-1/CXCR4/AKT signaling pathwayGuidelines for treatment and prevention of venous thromboembolism among patients with cancer.Clinical use of the low-molecular-weight heparins in cancer patients: focus on the improved patient outcomes.Analysis of incidence, risk factors and clinical outcome of thromboembolic and bleeding events in 431 allogeneic hematopoietic stem cell transplantation recipientsCancer, clots and consensus: new understanding of an old problem.Phosphatidylserine index as a marker of the procoagulant phenotype of acute myelogenous leukemia cells.Elevated neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio and decreased platelet-to-lymphocyte ratio are associated with poor prognosis in multiple myeloma.Congenital thrombophilia and central venous catheter-related thrombosis in patients with cancer.Thrombotic complications in multiple myeloma: a report of three cases and review of the literature.Risk assessment models for cancer-associated venous thromboembolism.Pathogenesis and treatment of thrombohemorrhagic diathesis in acute promyelocytic leukemia.Thrombosis in multiple myeloma (MM).Do circulating tumor cells play a role in coagulation and thrombosis?Coagulation and cancer: biological and clinical aspects.Anticoagulation for prevention and treatment of cancer-related venous thromboembolism.Characterization of incidental cardiac masses in oncological patients using a new CT-based tumor volume perfusion technique.Thrombosis in pediatric cancer: identifying the risk factors to improve care.Hairy cell leukaemia and venous thromboembolism: a case report and review of the literature.Multiple Myeloma: Cast Nephropathy, VTE, and Neurologic Complications.Thromboembolic risk in hematological malignancies.Development of coagulation factor probes for the identification of procoagulant circulating tumor cells.Absence of tissue factor expression by neoplastic plasma cells in multiple myeloma.Recurrence of Venous Thromboembolism in Patients With Cancer Treated With WarfarinIntegrative Analysis with Monte Carlo Cross-Validation Reveals miRNAs Regulating Pathways Cross-Talk in Aggressive Breast Cancer.
P2860
Q24631121-0FB6BA77-121D-4CD7-99E2-48306B7391D7Q26741697-67722527-CB98-470C-AB43-E29ADD26F8D5Q26823292-69772F48-10F0-4EF7-96B2-63266132F76FQ26827538-EBC0FC44-3C16-498A-9967-403CE4D743F2Q26852015-09EBDDD8-7452-4E7A-A406-16C0061352EFQ33395628-7B3E37EB-62EA-4C88-95AF-D7A4D94C8F8CQ33397129-642417AE-2DD3-471E-A862-3C4EA0731E59Q33419213-F4347D7F-F3C5-41FB-84F0-E4C7A15A62E6Q33419224-CDA57E4B-B92C-4635-AEEA-80DB699AFBCBQ33425797-C844B4BC-0247-46F6-B8A6-2F02C60E36AAQ33428591-D82856A0-FCA8-4642-BB49-FCE2C6D54021Q33429840-E5338C57-C17C-454D-87EA-5284F04480E8Q33438981-E99533A2-84D2-47D9-AE02-F1ADCFFF374AQ33563067-59A97096-9F21-4210-AE2B-02212735F8F0Q33862707-7ACB1601-A10E-4BE7-A8C5-23DD2B030F66Q34250240-B5CDD9B0-CD42-4619-8B9B-77C7660D6B8DQ34898664-4F82477D-CA87-416C-A1B1-EB90D8F18B20Q35174604-5444A619-D0ED-4ECA-9D4B-7C1394B49276Q35368813-F67F0C66-0195-45FA-AEE3-D65E190934BFQ36862372-32F97452-A7D6-4D7E-B173-415A0C6A2A94Q37393386-704AB72C-6BCF-4E2C-8EDA-14948733FADCQ37419736-D398D7F2-D33F-4DC4-B160-ED4128837F80Q37745835-FF04BED7-B78B-4069-899E-B932F833CEBEQ37763366-408DEB36-DAF3-454B-9E91-F0391560FA08Q37929631-FE186BB1-8A4C-4E32-9672-950C8A5C833EQ37956590-A49EAEC7-A208-4C6D-A450-4639A208F7E7Q37973346-F18DDA56-4EB8-41FB-BA87-A0216033EA80Q38003019-B41515CE-AEB4-4892-9466-10BBFBE8C9C7Q38042949-39C351D4-3895-425C-8C01-3256A5FE95B3Q38070918-5D1CE7DC-A8B4-47C3-B5DC-3780CA36DD94Q38096441-81B6591C-700C-4C5C-8127-3AD37F26661FQ38119477-FFCF522D-C376-410E-9898-A96A2ED3D617Q38152512-DF44E960-913D-4A79-895E-4DC91E253742Q38220479-27BAADFA-D37A-4108-8A18-DE08EC505023Q38230423-9138941C-DB87-4AF4-934C-7EEB13A3FA2BQ38287304-23054A7A-EEEA-462E-BA54-ECB82A3B8882Q39279785-AB0CF172-8CD2-40C0-B0DA-878E575C49C6Q39396683-A6636743-C905-4385-B2C2-D60DC8FBC3F4Q41705428-922F029F-30D8-4F7B-AB58-579DA25FFBF7Q42381466-E8DC912F-071D-4D0C-BB44-CC61BED9AE9B
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Venous thromboembolism in the hematologic malignancies.
@en
Venous thromboembolism in the hematologic malignancies.
@nl
type
label
Venous thromboembolism in the hematologic malignancies.
@en
Venous thromboembolism in the hematologic malignancies.
@nl
prefLabel
Venous thromboembolism in the hematologic malignancies.
@en
Venous thromboembolism in the hematologic malignancies.
@nl
P356
P1476
Venous thromboembolism in the hematologic malignancies
@en
P2093
Anna Falanga
Marina Marchetti
P304
P356
10.1200/JCO.2009.22.8197
P407
P577
2009-09-14T00:00:00Z